Kieren Anne Marr is an infectious diseases specialist focused on preventing infectious complications in people with immune deficiencies. She was the inaugural Medical Director of the Transplant and Oncology Infectious Diseases Program at Johns Hopkins University (JHU) and Professor of Medicine, Oncology and Business until her retirement from JHU in 2022. She is known worldwide for translational and clinical research on diagnostics and therapies for invasive fungal infections, has authored over 300 peer-reviewed publications, edited three books, and is Associate Editor of Principles and Practice of Infectious Diseases, the field’s most referenced textbook. She is an elected member of the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI), where she served on leadership council from 2015 to 2018 and then as President in 2019. She has been recognized for her contributions to the field of Infectious Diseases with a number of awards, including being named by Thomson Reuters as one of the “World’s Most Influential Scientific Minds”

Dr. Marr’s interest in healthcare innovation and entrepreneurship led her to earning an MBA at MIT Sloan School of Business in 2018. She served as the JHU Vice Chair of Medicine for Innovation 2016-22, and has cofounded two companies, including Elion Therapeutics, for which she is currently serving as Chief Medical Officer.